{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:21:16Z","timestamp":1762341676037,"version":"3.40.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.intimp.2021.107881","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:02:00Z","timestamp":1625702520000},"page":"107881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Serum free light chain is associated with histological activity and cirrhosis in patients with chronic hepatitis B"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1362-4296","authenticated-orcid":false,"given":"Baode","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixiong","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6159-9879","authenticated-orcid":false,"given":"Min","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2021.107881_b0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12072-018-9884-8","article-title":"Global HBV burden: guesstimates and facts","volume":"12","author":"Ginzberg","year":"2018","journal-title":"Hep. Intl."},{"issue":"4","key":"10.1016\/j.intimp.2021.107881_b0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4110\/in.2015.15.4.191","article-title":"Immune-mediated Liver Injury in Hepatitis B Virus Infection","volume":"15","author":"Oh","year":"2015","journal-title":"Immune Netw."},{"key":"10.1016\/j.intimp.2021.107881_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00849","article-title":"Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches","volume":"11","author":"Fisicaro","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107881_b0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.intimp.2016.03.005","article-title":"Circulating T follicular helper cells are associated with rapid virological response in chronic hepatitis C patients undergoing peginterferon therapy","volume":"34","author":"Zhang","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107881_b0025","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/cmi.2017.132","article-title":"Humoral immunity, the underestimated player in hepatitis B","volume":"15","author":"Zhang","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107881_b0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/hep.1840190207","article-title":"Quantitative assessment of serum Igm anti-Hbc in the natural course and during interferon treatment of chronic hepatitis-B virus-infection","volume":"19","author":"Marinos","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2021.107881_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02308","article-title":"Toward a functional cure for hepatitis B: the rationale and challenges for therapeutic targeting of the B cell immune response","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Immunol."},{"issue":"48","key":"10.1016\/j.intimp.2021.107881_b0040","doi-asserted-by":"crossref","first-page":"E11369","DOI":"10.1073\/pnas.1809028115","article-title":"Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.intimp.2021.107881_b0045","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.biocel.2004.09.007","article-title":"B cells","volume":"37","author":"Ollila","year":"2005","journal-title":"Int J Biochem Cell B"},{"issue":"11\u201312","key":"10.1016\/j.intimp.2021.107881_b0050","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cca.2011.03.007","article-title":"Free immunoglobulin light chain: its biology and implications in diseases","volume":"412","author":"Nakano","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.intimp.2021.107881_b0055","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajh.25791","article-title":"Multiple myeloma: 2020 update on diagnosis, risk-stratification and management","volume":"95","author":"Rajkumar","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.intimp.2021.107881_b0060","article-title":"Free immunoglobulin light chain (FLC) promotes murine colitis and colitis-associated colon carcinogenesis by activating the inflammasome","volume":"7","author":"Ma","year":"2017","journal-title":"Sci Rep-Uk"},{"issue":"10","key":"10.1016\/j.intimp.2021.107881_b0065","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1093\/cid\/cis692","article-title":"Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals","volume":"55","author":"Shiels","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2021.107881_b0070","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.autrev.2019.03.003","article-title":"Free light chains and autoimmunity","volume":"18","author":"Napodano","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2021.107881_b0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00011-020-01357-7","article-title":"Immunoglobulin free light chains: an inflammatory biomarker of diabetes","volume":"69","author":"Matsumori","year":"2020","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.intimp.2021.107881_b0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2009.25.1322","article-title":"Circulating serum free light chains as predictive markers of AIDS-related lymphoma","volume":"28","author":"Landgren","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107881_b0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.14218\/JCTH.2016.00019","article-title":"C.M.A. Chinese Society of Hepatology, C.M.A. Chinese Society of Infectious Diseases, guideline of prevention and treatment for chronic hepatitis B (2015 update)","volume":"5","author":"Hou","year":"2017","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"1Pt1","key":"10.1016\/j.intimp.2021.107881_b0090","first-page":"15","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C","volume":"20","author":"The French METAVIR Cooperative Study Group","year":"1994","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2021.107881_b0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2021.107881_b0100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archinte.163.2.218","article-title":"Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease","volume":"163","author":"Giannini","year":"2003","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/j.intimp.2021.107881_b0105","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.intimp.2021.107881_b0110","doi-asserted-by":"crossref","first-page":"e68780","DOI":"10.1371\/journal.pone.0068780","article-title":"RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.intimp.2021.107881_b0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.intimp.2021.107881_b0120","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2893.2004.00507.x","article-title":"Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection","volume":"11","author":"Watt","year":"2004","journal-title":"J. Viral. Hepat."},{"issue":"10","key":"10.1016\/j.intimp.2021.107881_b0125","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2893.2006.00744.x","article-title":"Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection","volume":"13","author":"Schmilovitz-Weiss","year":"2006","journal-title":"J. Viral. Hepat."},{"issue":"1","key":"10.1016\/j.intimp.2021.107881_b0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/infdis\/jiu388","article-title":"Aberrant serum immunoglobulin G glycosylation in chronic hepatitis B is associated with histological liver damage and reversible by antiviral therapy","volume":"211","author":"Ho","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2021.107881_b0135","doi-asserted-by":"crossref","DOI":"10.1111\/jgh.14123","article-title":"Enhanced B-cell differentiation driven by advanced cirrhosis resulting in hyperglobulinemia","author":"Doi","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107881_b0140","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.1840090518","article-title":"The liver and IgA: immunological, cell biological and clinical implications","volume":"9","author":"Brown","year":"1989","journal-title":"Hepatology"},{"issue":"80","key":"10.1016\/j.intimp.2021.107881_b0145","first-page":"2301","article-title":"Significance of hyperglobulinemia in severe chronic liver diseases\u2013with special reference to the correlation between serum globulin\/IgG level and ICG clearance","volume":"54","author":"Tanaka","year":"2007","journal-title":"Hepatogastroenterology"},{"issue":"6","key":"10.1016\/j.intimp.2021.107881_b0150","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1309\/AJCP4INKZ6LYAQXW","article-title":"Extended use of serum free light chain as a biomarker in lymphoproliferative disorders: a comprehensive review","volume":"137","author":"Charafeddine","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"issue":"16","key":"10.1016\/j.intimp.2021.107881_b0155","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2174\/138161212800166059","article-title":"Immunobiology of antigen-specific immunoglobulin free light chains in chronic inflammatory diseases","volume":"18","author":"Groot Kormelink","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2021.107881_b0160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejphar.2005.12.065","article-title":"Free immunoglobulin light chains as target in the treatment of chronic inflammatory diseases","volume":"533","author":"van der Heijden","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107881_b0165","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/acr.20446","article-title":"Serum free light chains as biomarkers for systemic lupus erythematosus disease activity","volume":"63","author":"Aggarwal","year":"2011","journal-title":"Arthritis Care Res."},{"issue":"12","key":"10.1016\/j.intimp.2021.107881_b0170","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/jvh.12746","article-title":"Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents","volume":"24","author":"Schiavinato","year":"2017","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.intimp.2021.107881_b0175","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.biopha.2017.04.121","article-title":"The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases","volume":"91","author":"Esparvarinha","year":"2017","journal-title":"Biomed. pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"1","key":"10.1016\/j.intimp.2021.107881_b0180","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4049\/jimmunol.0901129","article-title":"Ig-free light chains play a crucial role in murine mast cell-dependent colitis and are associated with human inflammatory bowel diseases","volume":"185","author":"Rijnierse","year":"2010","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"4","key":"10.1016\/j.intimp.2021.107881_b0185","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.tips.2008.01.004","article-title":"Free immunoglobulin light chains: a novel target in the therapy of inflammatory diseases","volume":"29","author":"Thio","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2021.107881_b0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jhep.2011.05.024","article-title":"Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study","volume":"56","author":"Zarski","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2021.107881_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2017.07.007","article-title":"Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are associated with chronic hepatitis B virus (HBV) infection","volume":"51","author":"Zhao","year":"2017","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:12:42Z","timestamp":1730837562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921005178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"alternative-id":["S1567576921005178"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107881","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum free light chain is associated with histological activity and cirrhosis in patients with chronic hepatitis B","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107881"}}